Literature DB >> 1991889

Effect of H1 receptor stimulation on coronary artery diameter in patients with variant angina: comparison with effect of acetylcholine.

K Okumura1, H Yasue, K Matsuyama, K Matsuyama, Y Morikami, H Ogawa, K Obata.   

Abstract

It has been suggested that histamine is involved in the pathogenesis of coronary spasm but its exact role remains unclear. H1 receptor stimulation of the coronary artery was performed with a selective intracoronary infusion of histamine (2 micrograms/min) in 21 patients with variant angina after blockade of the H2 receptor with cimetidine (25 mg/kg) and its effect on the coronary artery diameter was examined. Intracoronary injection of acetylcholine was also performed in 19 of the 21 patients. Ergonovine (0.2 mg) was intravenously administered in one patient. The coronary artery diameter was measured with cinevideodensitometric analysis. A mean plasma histamine concentration in the coronary sinus increased from 4 x 10(-9) to 7 x 10(-8) M 5 min after histamine infusion into the left coronary artery (n = 18). Coronary spasm was induced in 6 patients (29%) with histamine, in 18 (95%) with acetylcholine and in 1 with ergonovine. The effect of histamine on the luminal diameter was analyzed at the site of spasm in the 26 coronary arteries in which spasm was induced by acetylcholine or ergonovine. Of the 20 coronary arteries with a normal arteriogram or a fixed stenosis less than or equal to 50% of luminal diameter, histamine decreased the diameter in 4, increased it in 14 (70%) and caused no change in 2; of the 6 coronary arteries with a fixed stenosis greater than or equal to 75%, histamine decreased the diameter in 5 and increased it in 1. In the coronary arteries in which spasm was not induced by either acetylcholine or ergonovine, histamine increased the diameter, especially in those without advanced atherosclerosis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991889     DOI: 10.1016/s0735-1097(10)80096-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

1.  Open heart surgery increases the levels of histamine in arterial and coronary sinus blood.

Authors:  G Valen; J Kaszaki; S Nagy; J Vaage
Journal:  Agents Actions       Date:  1994-03

Review 2.  The Roles of Cardiovascular H2-Histamine Receptors Under Normal and Pathophysiological Conditions.

Authors:  Joachim Neumann; Uwe Kirchhefer; Stefan Dhein; Britt Hofmann; Ulrich Gergs
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

3.  Expression of the histamine H1 receptor gene in relation to atherosclerosis.

Authors:  T Takagishi; Y Sasaguri; R Nakano; N Arima; A Tanimoto; H Fukui; M Morimatsu
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

4.  Norepinephrine-induced cardiac hypertrophy and fibrosis are not due to mast cell degranulation.

Authors:  Wilfried Briest; Beate Rassler; Alexander Deten; Heinz-Gerd Zimmer
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

5.  Cardiac release of histamine after ventricular fibrillation and defibrillation during insertion of implantable cardioverter defibrillators (ICD).

Authors:  G Valen; M Runsiö; A Owall; J Kaszaki; S Nagy; M Rosenqvist; L Bergfeldt; J Vaage
Journal:  Inflamm Res       Date:  1995-11       Impact factor: 4.575

6.  The effects of exogenous histamine in isolated rat hearts.

Authors:  G Valen; T Skjelbakken; J Vaage
Journal:  Mol Cell Biochem       Date:  1995-05-10       Impact factor: 3.396

7.  Editorial: Kounis syndrome (allergic angina and allergic myocardial infarction) for cardiologists.

Authors:  Shozo Sueda; Yasuhiro Sasaki; Hirokazu Habara; Hiroaki Kohno
Journal:  J Cardiol Cases       Date:  2015-08-14

8.  Recognizing Kounis Syndrome: A Report of Type 2 Kounis Syndrome and a Brief Review of Management.

Authors:  Britney Clemen; Ifeanyi Nwosu; Nnamdi Chukwuka; Nikhil L Cordeiro; Emeka Ibeson; Amit Gulati; Sergey Ayzenberg; Benjamin Weindorf
Journal:  Cureus       Date:  2021-11-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.